just took my first dose of semaglutide What to Expect After Injection: Complete Guide Ozempic® Pen Dosing | Ozempic®

GLP-1 receptor agonists are licensed in the UK for type 2 diabetes mellitus and specific weight management indications, not for cognitive impairment or dementia GLP-1 receptors are present in brain regions involved in memory and learning, prompting research into potential neuroprotective effects Ongoing clinical trials, including studies of semaglutide in Alzheimer's disease, are examining whether these medications benefit cognitive function Common adverse effects include gastrointestinal symptoms

PMID: 40125190 15 In older women, a high-protein diet including animal-sourced foods did not impact serum levels and urinary excretion of trimethylamine-N-oxide

KEY TAKEAWAYS Restricting calories on GLP-1 medications can lower your metabolic rate and weaken your body's natural GLP-1 production Liposuction during skin removal surgery may disrupt leptin signaling, though males may be less affected than females due to naturally lower leptin levels Finding metabolic-informed doctors globally remains challenging, but obesity medicine certification and Canadian and European obesity organizations may offer better resources The oral GLP-1 medication orforglipron will likely be less expensive but also less effective than dual-agonist medications like tirzepatide Mechanical eating without calorie counting often produces better long-term results than restrictive approaches Vegetables provide essential micronutrients and support healthy microbiome function that protein alone cannot replace Major weight loss surgery like tummy tucks is serious surgery that requires careful consideration and qualified surgeons NOTE: This episode was recorded before Foundayo (orforglipron) was released on the market

Stock solution notes fit documentation review when they are treated as internal laboratory records

GLP-1 medications are reshaping metabolic health, culture, consumer expectations, and the future of the food landscape

10.1016/j.biocel.2007.08.005 146 TianS.ChenM.WangB.HanY.ShangH.ChenJ